Haematology/Immunology Flashcards
(60 cards)
Hereditary angioedema
Autosomal dominant
Low plasma levels of the C1 inhibitor (C1-INH, C1 esterase inhibitor)
Serum C4 is the most reliable and widely used screening tool
Cancer patients with VTE
6 months of a DOAC
Pathogenesis of thrombotic thrombocytopenic purpura (TTP)
Abnormally large and sticky multimers of von Willebrand’s factor cause platelets to clump within vessels
In TTP there is a deficiency of ADAMTS13 (a metalloprotease enzyme) which breakdowns (‘cleaves’) large multimers of von Willebrand’s factor
Thrombotic thrombocytopenic purpura - features
Fever
Fluctuating neuro signs (micro-emboli)
Microangiopathic haemolytic anaemia
Thrombocytopenia
Renal failure
Initial treatment for CLL
Fludarabine, cyclophosphamide and rituximab (FCR)
Ibrutinib may be used in patients who have failed a previous therapy
The following groups of patients require CMV-negative blood
Intra-uterine transfusions
Neonates up to 28 days post expected date of delivery
Pregnancy
Fresh frozen plasma
Prepared from single units of blood.
Contains clotting factors, albumin and immunoglobulin.
Unit is usually 200 to 250ml.
Usually used in correcting clotting deficiencies in patients with hepatic synthetic failure who are due to undergo surgery.
Cryoprecipitate
Formed from supernatant of FFP.
Rich source of Factor VIII and fibrinogen.
Allows large concentration of factor VIII to be administered in small volume.
Hereditary spherocytosis - inheritance and pathophysiology
Northern European descent
Autosomal dominant
Red blood cell survival reduced as destroyed by the spleen
Diagnosis of Hereditary spherocytosis
EMA binding test
Long term treatment of Hereditary spherocytosis
Folate replacement
Splenectomy
1st line imaging in suspected multiple myeloma
Whole body MRI
Extravascular haemolysis: causes
Haemoglobinopathies: sickle cell, thalassaemia
Hereditary spherocytosis
Haemolytic disease of new-born
Warm autoimmune haemolytic anaemia
Smear/Smudge cells
Chronic lymphoblastic leukaemia (CLL)
Auer rods
Acute promyelocytic leukaemia
Basophilic stippling
Lead poisoning
Management of Lead Poisoning
Dimercaptosuccinic acid (DMSA)
Heinz bodies, bite and blister cells
G6PD deficiency
Hairy cell leukaemia - gene
BRAF
Management of Hereditary angioedema
IV C1-inhibitor concentrate or fresh frozen plasma if this is not available
Secondary causes of Polycythaemia
COPD
Altitude
Obstructive sleep apnoea
Warfarin-induced skin necrosis
While warfarin blocks the activation of clotting factors II, VII, IX, and X, it also deactivates protein C and protein S, two endogenous anticoagulants.3
Since protein C has a short half-life (8 hours) and warfarin initially decreases protein C levels faster than the coagulation factors, it can paradoxically increase the coagulation tendency when treatment is first begun, leading to massive thrombosis with skin necrosis and gangrene of limbs.
Reversal agent - Rivaroxaban and apixaban
Andexanet alfa
Reversal agent for dabigatran
Idarucizumab